Falcon Point Capital’s OptiNose OPTN Stock Holding History

Falcon Point Capital’s Portfolio OPTN Stock Details OPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-921	Closed	-$62K	–	85
2020 Q1	$62K	Sell	921 -139	-13%	-$14K	0.13%	94
2019 Q4	$147K	Hold	1,060	–	–	0.19%	104
2019 Q3	$124K	Buy	+1,060	New	+$106K	0.07%	103

Other funds holding OPTN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Falcon Point Capital's OPTN Position: Q2 2020 in Review

Falcon Point Capital sold out of OptiNose (OPTN) in Q2 2020, closing a stake of 921 shares — an estimated $62K sold.

Falcon Point Capital first reported a position in OPTN in Q3 2019 and held it in 3 quarters. The position peaked at $147K in Q4 2019. 72 funds tracked by Wall St. Rank hold OPTN as of Q2 2020.

Falcon Point Capital reported no remaining OptiNose position as of Q2 2020 after selling out during the quarter.
Falcon Point Capital sold 921 OptiNose shares in Q2 2020, an estimated $62K.
Falcon Point Capital first reported a position in OptiNose in Q3 2019 and held it in 3 quarters.
Falcon Point Capital's OptiNose position peaked at $147K in Q4 2019.
72 funds tracked by Wall St. Rank held OptiNose as of Q2 2020.

Based on Falcon Point Capital's 13F filing for Q2 2020, filed 21 Jul 2020.